Inventor
WIRTH KLAUS
DE58 patents
⚠️ This page may combine multiple inventors who share the name “WIRTH KLAUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANOFI AVENTIS DEUTSCHLAND
9 patentsUS7241775B2Jul 10, 2007
Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines
SANOFI AVENTIS DEUTSCHLAND65 citations98
US7049333B2May 23, 2006
Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
SANOFI AVENTIS DEUTSCHLAND14 citations92
US7790742B2Sep 7, 2010
Substituted 4-phenyltetrahydroisoquinolines, pharmaceutical compositions thereof, methods for their preparation and therapeutic use
SANOFI AVENTIS DEUTSCHLAND22 citations91
US7442717B2Oct 28, 2008
Substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid
SANOFI AVENTIS DEUTSCHLAND4 citations63
US7317033B2Jan 8, 2008
Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
SANOFI AVENTIS DEUTSCHLAND2 citations62
US7763643B2Jul 27, 2010
Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
SANOFI AVENTIS DEUTSCHLAND0 citations51
US7488746B2Feb 10, 2009
Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
SANOFI AVENTIS DEUTSCHLAND0 citations51
US7179830B2Feb 20, 2007
Substituted thienoimidazoles useful for disease treatment and prevention
SANOFI AVENTIS DEUTSCHLAND1 citations51
US7179829B2Feb 20, 2007
Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them
SANOFI AVENTIS DEUTSCHLAND0 citations42
AVENTIS PHARMA GMBH
9 patentsUS6911453B2Jun 28, 2005
Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
AVENTIS PHARMA GMBH81 citations97
US6737423B2May 18, 2004
Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them
AVENTIS PHARMA GMBH38 citations92
US6703405B2Mar 9, 2004
Substituted 4-phenyltetrahydroisoquinolinium salts, process for their preparation, their use as a medicament, and medicament containing them
AVENTIS PHARMA GMBH47 citations92
US6211196B1Apr 3, 2001
Benzyloxy-substituted, fused N-heterocycles, processes for their preparation, and their use as bradykinin receptor antagonists
AVENTIS PHARMA GMBH17 citations84
US6825231B2Nov 30, 2004
Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them
AVENTIS PHARMA GMBH8 citations74
US6958357B2Oct 25, 2005
Substituted benzimidazoles, processes for their preparation, their use as medicaments, and medicaments comprising them
AVENTIS PHARMA GMBH6 citations73
US6686384B2Feb 3, 2004
Substituted benzimidazoles, processes for their preparation, their use as medicaments, and medicaments comprising them
AVENTIS PHARMA GMBH12 citations73
US6414030B1Jul 2, 2002
Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptors blockers
AVENTIS PHARMA GMBH6 citations62
US6245736B1Jun 12, 2001
Use of peptidic bradykinin antagonists for the treatment and prevention of Alzheimer's disease
AVENTIS PHARMA GMBH5 citations62
HOECHST AG
8 patentsUS5786365AJul 28, 1998
Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith
HOECHST AG15 citations74
US5859025AJan 12, 1999
Fluoroalkyl- and fluoroalkoxy-substituted heterocyclic bradykinin antagonists, process for their preparation, and their use
HOECHST AG12 citations73
US5091365AFeb 25, 1992
Cyclic peptides as promoters of absorption on administration onto the mucosa
HOECHST AG16 citations67
US6140341AOct 31, 2000
Aminoalkyl and acylaminoalkyl ethers, process for their preparation, and their use as bradykinin receptor antagonists
HOECHST AG5 citations62
US5834500ANov 10, 1998
Sulfur-containing heterocyclic bradykinin antagonists, process for their preparation, and their use
HOECHST AG6 citations62
US5597803AJan 28, 1997
Bradykinin peptides with modifications at the N terminus
HOECHST AG6 citations62
US5789383AAug 4, 1998
Bradykinin antagonists for the prophylaxis or treatment of virus diseases
HOECHST AG4 citations61
US5863901AJan 26, 1999
Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders
HOECHST AG1 citations52
SANOFI SA
8 patentsUS9284333B2Mar 15, 2016
Fused pyrroledicarboxamides and their use as pharmaceuticals
SANOFI SA5 citations71
US9120783B2Sep 1, 2015
Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
SANOFI SA2 citations61
US9884860B2Feb 6, 2018
Fused pyrroledicarboxamides and their use as pharmaceuticals
SANOFI SA1 citations51
US9598410B2Mar 21, 2017
Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridines, their use as medicament, and pharmaceutical preparations comprising them
SANOFI SA0 citations51
US9029559B2May 12, 2015
Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
SANOFI SA0 citations51
US9751858B2Sep 5, 2017
3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
SANOFI SA1 citations50
US9550788B2Jan 24, 2017
Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
SANOFI SA0 citations50
US9440941B2Sep 13, 2016
Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals
SANOFI SA2 citations50
RUF SVEN
3 patentsUS8669370B2Mar 11, 2014
Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
RUF SVEN0 citations49
US9353068B2May 31, 2016
3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
RUF SVEN1 citations48
US8664257B2Mar 4, 2014
Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
RUF SVEN1 citations48
SCHWINK LOTHAR
2 patentsHOECHST MARION ROUSSEL DE GMBH
1 patentBOSCH GMBH ROBERT
1 patentLUCENT TECHNOLOGIES INC
1 patentBIALY LAURENT
1 patentBRENDEL JOACHIM
1 patentADOLF WUERTH GMBH & CO KG
1 patentWIRTH GMBH
1 patentCZECHTIZKY WERNGARD
1 patentSANOFI AVENTIS
1 patentHEINELT UWE
1 patentRACKELMANN NILS
1 patentShowing the top 50 of 58 patents by PatentIndex Score.